Literature DB >> 32927573

Hypervirulence and cross-resistance to a clinical antifungal are induced by an environmental fungicide in Cryptococcus gattii.

Hellem Cristina Silva Carneiro1, Rafael Wesley Bastos2, Noelly Queiroz Ribeiro1, Ludmila Gouveia-Eufrasio3, Marliete Carvalho Costa1, Thais Furtado Ferreira Magalhães1, Lorena Vívien Neves Oliveira4, Tatiane Alves Paixão5, Luna Sobrino Joffe6, Marcio L Rodrigues7, Glauber Ribeiro de Sousa Araújo8, Susana Frases8, Jeronimo Conceição Ruiz9, Paula Marinho10, Jônatas Santos Abrahão10, Maria Aparecida Resende-Stoianoff1, Dee Carter11, Daniel Assis Santos12.   

Abstract

The increasing human population requires ongoing efforts in food production. This is frequently associated with an increased use of agrochemicals, leading to environmental contamination and altering microbial communities, including human fungal pathogens that reside in the environment. Cryptococcus gattii is an environmental yeast and is one of the etiological agents of cryptococcosis. Benomyl (BEN) is a broad-spectrum fungicide used on several crops. To study the effects of agrochemicals on fungal pathogens, we first evaluated the susceptibility of C. gattii to BEN and the interactions with clinical antifungals. Antagonistic interaction between BEN and fluconazole was seen and was strain- and concentration-dependent. We then induced BEN-resistance by culturing strains in increasing drug concentrations. One strain demonstrated to be more resistant and showed increased multidrug efflux pump gene (MDR1) expression and increased rhodamine 6G efflux, leading to cross-resistance between BEN and fluconazole. Morphologically, BEN-adapted cells had a reduced polysaccharide capsule; an increased surface/volume ratio; increased growth rate in vitro and inside macrophages and also higher ability in crossing an in vitro model of blood-brain-barrier. BEN-adapted strain demonstrated to be hypervirulent in mice, leading to severe symptoms of cryptococcosis, early mortality and higher fungal burden in the organs, particularly the brain. The parental strain was avirulent in murine model. In vivo cross-resistance between BEN and fluconazole was observed, with mice infected with the adapted strain unable to present any improvement in survival and behavior when treated with this antifungal. Furthermore, BEN-adapted cells cultured in drug-free media maintained the hypervirulent and cross-resistant phenotype, suggesting a persistent effect of BEN on C. gattii. In conclusion, exposure to BEN induces cross-resistance with fluconazole and increases the virulence of C. gattii. Altogether, our results indicate that agrochemicals may lead to unintended consequences on non-target species and this could result in severe healthy problems worldwide.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Agrochemicals; Antifungals; Cross-resistance; Cryptococcosis; Fungi

Mesh:

Substances:

Year:  2020        PMID: 32927573     DOI: 10.1016/j.scitotenv.2020.140135

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   7.963


  4 in total

1.  Lack of Association between Fluconazole Susceptibility and ERG11 Nucleotide Polymorphisms in Cryptococcus neoformans Clinical Isolates from Uganda.

Authors:  Priscilla Belbir Atim; David B Meya; Elliot S Gerlach; Dennis Muhanguzi; Allan Male; Benedict Kanamwanji; Kirsten Nielsen
Journal:  J Fungi (Basel)       Date:  2022-05-15

Review 2.  Tackling the emerging threat of antifungal resistance to human health.

Authors:  Matthew C Fisher; Ana Alastruey-Izquierdo; Judith Berman; Tihana Bicanic; Elaine M Bignell; Paul Bowyer; Michael Bromley; Roger Brüggemann; Gary Garber; Oliver A Cornely; Sarah J Gurr; Thomas S Harrison; Ed Kuijper; Johanna Rhodes; Donald C Sheppard; Adilia Warris; P Lewis White; Jianping Xu; Bas Zwaan; Paul E Verweij
Journal:  Nat Rev Microbiol       Date:  2022-03-29       Impact factor: 78.297

Review 3.  Fungicide effects on human fungal pathogens: Cross-resistance to medical drugs and beyond.

Authors:  Rafael W Bastos; Luana Rossato; Gustavo H Goldman; Daniel A Santos
Journal:  PLoS Pathog       Date:  2021-12-09       Impact factor: 6.823

Review 4.  Is antimicrobial resistance evolution accelerating?

Authors:  Christopher Witzany; Sebastian Bonhoeffer; Jens Rolff
Journal:  PLoS Pathog       Date:  2020-10-22       Impact factor: 6.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.